Metraipolis › archive › dc_09b5e18783be
Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/28984776
- DOI
- 10.1097/md.0000000000008223
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T08:10:08.154Z
- SHA-256 of the archived text
76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67- Stable URL of this page
https://metraipolis.com/documento/dc_09b5e18783be
How to cite
Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776 — Europe PMC (en), https://europepmc.org/article/MED/28984776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09b5e18783be (Metraipolis archive dc_09b5e18783be, sha256 76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67)
BibTeX
@misc{dc09b5e18783be,
title = {Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute… — Europe PMC PMID:28984776},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/28984776},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09b5e18783be; sha256 76363c62dd48176a19403de8fa43e8bec1dc4afd7a4d6f06d14e44a596194e67},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28984776. Agents can read the archived copy with the MCP tool read_document.